+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs

  • ID: 4655919
  • Report
  • Region: Singapore
  • 77 Pages
  • Ken Research Private Limited
1 of 4
Singapore Pharmaceutical Market has Increased at a Single Digit CAGR During 2012-2017

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • Baxter
  • Beacon Pharmaceuticals
  • GSK
  • Haw Par Corporation
  • MORE

The report titled ""Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs"" covers aspects such as pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), competitive landscape of major players in the Singapore pharmaceutical market including Haw Par Corporation, Beacon Pharmaceuticals, GSK, Singapore, Roche, Singapore, AstraZeneca, Singapore, Lonza, Singapore, Baxter, Singapore, Abbott, Singapore, MSD, Singapore, Sunward Pharmaceutical, Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia Pacific Pte Ltd, and Chemical Company of Malaysia Berhad,.

The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • Baxter
  • Beacon Pharmaceuticals
  • GSK
  • Haw Par Corporation
  • MORE

1. Research Methodology        
1.1. Market Definitions
1.2. Abbreviations
1.3. Consolidated Research Approach
1.4. Market Sizing and Limitation
1.5. Variables (Dependent and Independent)
1.6. Singapore Hospital Market Correlation Matrix
1.7. Singapore Hospital Market Regression Matrix

2. Singapore Pharmaceutical Market – Executive Summary

3. Singapore Pharmaceutical Ecosystem
3.1. Value Chain in Singapore Pharmaceuticals Market

4. Singapore Healthcare System

5. Singapore Healthcare Key Metrics

6. Comparative Analysis with Other Asian Countries

7. Regulatory Bodies in Singapore Healthcare System

8. Singapore Pharmaceutical Market
8.1. Overview and Market Nature
8.2. Market Size, 2012-2017

9. Singapore Pharmaceutical Market Segmentation
9.1. by Patented and Generic Drugs, 2014-2017
9.2. by Prescription and OTC Drugs, 2014-2017
9.2.1. Singapore Over-The-Counter Drugs Market Size
9.2.2. Singapore Over-The-Counter Drugs Market: Competition
9.2.3. Pricing Scenario in Singapore Over-The-Counter Drugs Market

10. Singapore Pharmaceutical Market Recent Developments & Growth Drivers

11. Singapore Pharmaceutical Market– Restraints

12. Government Regulations for Singapore Pharmaceutical Market

13. New Drug Approvals in Singapore, 2017

14. Singapore Pharmaceutical Market Competition Analysis
14.1. Singapore Pharmaceutical Market – Competition Analysis
14.2. Singapore Pharmaceutical Market Competitive Landscape
14.2.1. Company Profile: Haw Par Corporation Limited
14.2.2. Company Profile: Beacon Pharmaceuticals
14.2.3. Company profile: GSK, Singapore
14.2.4. Major companies in Singapore Pharmaceutical Market

15. Singapore Pharmaceutical Market: Future Outlook and Projections
15.1. Singapore Pharmaceuticals Market-Future Outlook and Projections, 2018-2022
15.2. Singapore Pharmaceutical Market-Future by Generic and Patented Drugs, 2017-2022

16. Snapshot on Singapore Vitamin and Dietary Supplement Market
16.1. Market Size, 2012-2017
16.2. Competition Scenario
16.3. Pricing Scenario

17. Snapshot for Singapore Animal Healthcare

18. Snapshot for Singapore Biopharmaceutical Market

19. Singapore Pharmaceutical Market – Analyst Recommendations

20. Disclaimer
 
List Of Tables
Table 1.1: Therapeutic Segments Covered in Singapore Pharmaceutical Market
Table 1.2: Correlation Matrix for Singapore Hospital Market
Table 1.3: Regression Coefficient Output for Singapore Hospital Market
Table 5.1: Singapore Healthcare Market Key Metrics, 2017
Table 5.2: Singapore Healthcare Personnel, 2017
Table 5.3: Incidence/Prevalence of Major Diseases, 2016
Table 5.4: Number of Cases of Major Infectious Diseases in Singapore, 2012-2017
Table 6.1: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia , South Korea, India, China and Australia, 2016
Table 6.2: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia , South Korea, India, China and Australia, 2017
Table 9.1: Market Share of Major Companies in Singapore Over-The-Counter Drugs Market on the Basis of Revenue in SGD Million, 2012-2017
Table 9.2: Singapore Over-The-Counter Drugs Market Pricing of Major Products by Category, Brand Name and Company
Table 12.1: Classification of Drugs in Singapore
Table: 12.2: Type of Application for Registration of a Therapeutic Product In Singapore     
Table 12.3: Evaluation Routes for Registration of a Therapeutic Product In Singapore     
Table 12.4: Fees for Therapeutic Product Registration
Table 13.1: New Drug Approvals in Singapore, 2017
Table 14.1: Major Competition Parameters for Singapore Pharmaceutical market
Table 14.2: Strengths and Weaknesses of Major Players in Singapore Pharmaceutical Market
Table 14.3: Competitive Landscape  for Haw Par Corporation including Overview, Recent Developments, Products and Future Strategies
Table 14.4: Competitive Landscape for Beacons Pharmaceuticals including Overview, Facility, Services and Major Clients
Table 14.5: Competitive Landscape for GSK, Singapore including Overview, Facility, Recent Developments and Future Strategy
Table 14.6: Major Companies in Singapore Pharmaceutical Market including Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia pacific Pte  Ltd, Chemicals Company of Malaysia Berhad, Sunward Pharmaceutical, Sphaera Pharma Private Ltd, Roche, Singapore, Lonza, AstrZeneca, Baxter, Abbott, and MSD
Table 15.1: Singapore Prescription Drugs Market Future Outlook by Patented and Generic by Revenues in SGD Billion, 2022
Table 16.1: Consumer Behavior in Singapore Vitamin and Dietary Supplements Market
Table 16.3: Pricing of Major Vitamins & Dietary Supplements by Brand Name and Company in Singapore
Table 17.1: Snapshot on Singapore Animal Healthcare Market
Table 18.1: Snapshot for Singapore Biopharmaceutical Market
 
List Of Figures
Figure 2.1: Singapore Pharmaceutical Market Size by Revenue in SGD Billion, 2012, 2017 and 2022
Figure 2.2: Singapore Pharmaceutical Market Segmentation by Drug on the Basis of Revenue, 2017-2022
Figure 2.3: Singapore Over-The-Counter Drugs Market Size on the Basis of Revenue in SGD Million, 2012, 2015 and 2017
Figure 3.1: Value Chain in Singapore Pharmaceutical Market
Figure 4.1: Singapore Healthcare System
Figure 5.1: Top Causes of Death in Singapore, 2016
Figure 8.1: Singapore Pharmaceutical Market Size on the Basis of Revenue in SGD Billion and Growth Rate in Percentage (%) , 2012-2017
Figure 8.2: Singapore Pharmaceutical Market Size on the Basis of Number of Workers, 2012-2017
Figure 8.3: Singapore Pharmaceutical Market Size on the Basis of Number of Establishments, 2012-2016
Figure 9.1: Singapore Prescription Drugs Market Segmentation by Patented and Generic by Revenues in Percentage (%), 2017
Figure 9.2: Singapore Pharmaceutical Market Segmentation by OTC and Prescription Drugs by Revenues in Percentage (%), 2014 and 2017
Figure 9.3: Singapore Over-The-Counter Drugs Market Size on the Basis of Revenue in SGD Million and Growth Rate in Percentage (%), 2012-2017
Figure 9.4: Market Share of Major Companies in Singapore Over-The-Counter Drugs Market on the Basis of Revenue in percentage (%), 2017
Figure 14.1: Key Metrics of Singapore Pharmaceutical Market-2017
Figure 14.2: Haw Par Corporation Healthcare Revenue from ASEAN Countries, 2012-2016
Figure 15.1: Singapore Pharmaceutical Market Future Projection by Revenue in SGD Billion, 2018-2022
Figure 15.2: Singapore Pharmaceuticals Market Future Projection by Number of Establishments, 2018-2022
Figure 15.3: Singapore Prescription Drugs Market Future Outlook by Patented and Generic by Revenues in Percentage (%), 2017
Figure 16.1: Singapore Vitamin and Dietary Supplement Market Revenue in USD Million, 2012-2017
Figure 16.2: Singapore Vitamin and Dietary Supplements Market by Major Companies on the Basis of Revenue in Percentage (%), 2017

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • Baxter
  • Beacon Pharmaceuticals
  • GSK
  • Haw Par Corporation
  • MORE

Executive Summary
The report titled “Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs” covers aspects such as pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), competitive landscape of major players in the Singapore pharmaceutical market including Haw Par Corporation, Beacon Pharmaceuticals, GSK, Singapore, Roche, Singapore, AstraZeneca, Singapore, Lonza, Singapore, Baxter, Singapore, Abbott, Singapore, MSD, Singapore, Sunward Pharmaceutical, Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia Pacific Pte Ltd, and Chemical Company of Malaysia Berhad,.

The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore Pharmaceutical Market

Singapore Pharmaceutical market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research and access to regional markets and skilled workforce. Singapore Pharmaceutical market has registered an increase in the revenue during the period 2012-2017. Many leading biomedical companies such as AbbVie, Pfizer, Ferring Pharmaceuticals and others have selected Singapore as their global manufacturing base.

Singapore pharmaceutical market has increased at a single digit CAGR during 2012-2017.

Singapore has emerged as one of the most integrated and advanced hubs for pharmaceutical manufacturing and research in Southeast Asia. Singapore has developed 2 biomedical hubs namely Biopolis and Tuas Biomedical Park. Biopolis facilitates the cooperation between public sector research centers with private labs whereas the Tuas Biomedical Park is dedicated primarily to pharmaceutical manufacturing and production.

Singapore Pharmaceutical Market Segmentation

By Prescription & OTC Drugs: Prescription drugs have accounted for largest share of the revenue in Singapore pharmaceutical market in 2017. OTC drugs have accounted for the remaining share of the revenue. The growth in prescription drugs can be attributed to prevalence of chronic diseases such as diabetes, cancer and others have further driven prescription drugs sale. Sale of OTC drugs has been on an incline owing to rise in trend of self-medication in Singapore. The majority of antibiotics are sold via OTC channel. Vitamins and dietary supplements are one of the fastest growing segments of OTC.

By Patented & Generic Drugs: Patented drugs have accounted for largest share of the revenue in Singapore prescription drugs market in 2017. Generic drugs have accounted for the remaining share in terms of revenues. The presence of secure IP protection has encouraged international companies to set up manufacturing facilities and gain patent rights for their drugs, API and production process.

Further, it is supported by the availability of modern infrastructure and large investment in research activities. These include drugs for infectious diseases and oncology.

Singapore Over-The-Counter Drugs Market
Singapore OTC market increased at a double digit CAGR during 2012-2017. The market is driven by increasing number of people taking self-medication. Further, increased focus on R&D efforts has led to better focus on the advancement of innovative over-the-counter and consumer health drugs.

Major therapeutic segments include antibiotics, analgesics and antacids. Since these medicines do not require a prescription, the manufacturers are also able to sell them through online retail channels. Leading companies in the OTC market include GlaxoSmithKline Plc, Reckitt Benckiser Group Plc (RB), Ricola AG, Lofthouse of Fleetwood Ltd, Haw Par Corp Ltd and Valeant Pharmaceuticals International Inc

Singapore Pharmaceutical Market Competition Overview
The market is fragmented with multinational companies dominating the space with major focus on research & development activities. There are 54 pharmaceutical manufacturers and 5,500 registered medicines as of 2017. Major multinational companies include GSK, Novartis, Roche, Pfizer, Bayer, AstraZeneca, Abbott, Baxter, Maccine and others.

The pharmaceutical market has witnessed increasing advancement of innovative over-the-counter, generic, prescription and consumer health drugs. Major competition parameters include product range, distribution network, technology, investment in R&D

Singapore Pharmaceutical Market Future Potential
Singapore pharmaceutical market is expected to grow at a single digit CAGR during 2017-2018 driven by universal access to health insurance and world-class biomedical research facilities.
The best in class research and manufacturing infrastructure will continue to attract foreign investment in the country. For instance, Japan’s Chugai Pharmaceutical, which operates satellite labs throughout Asia, has plans to invest USD 355 million by 2021, to accelerate its research and development (R&D) capabilities in Singapore.

The industry will witness a rise in development of technology to support automation and increase productivity. For instance, GSK has been pioneering a technology called continuous manufacturing where instead of making products in batches, materials are constantly added and products removed. Big global drug makers ramp up output and advance automation at their production sites across the country.  

Key Topics Covered in the Report:

  • Singapore Pharmaceutical Market Size, 2012-2017
  • Singapore Pharmaceutical Market Segmentation (by Prescription & OTC Drugs, by Patented & Generic Drugs)
  • Singapore Over-The-Counter Market Size
  • Trends and Developments in Singapore Pharmaceutical Market
  • Issues and Challenges in Singapore Pharmaceutical Market
  • Government Initiatives, Rules and Regulations in Singapore Pharmaceutical Market
  • Singapore Pharmaceutical Market Competitive Landscape
  • Singapore Pharmaceutical Future Outlook and Projections, 2018-2022
  • Value Chain in Singapore Pharmaceutical Industry
  • Analyst Recommendations
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • AstraZeneca
  • Baxter
  • Beacon Pharmaceuticals
  • Chemical Company of Malaysia Berhad
  • GSK
  • Haw Par Corporation
  • Lonza
  • MSD
  • Poli Medical
  • Roche
  • Schwabe Pharma Asia Pacific Pte Ltd
  • Sunward Pharmaceutical
  • Union Chemicals and Pharmaceuticals Pte Ltd
Note: Product cover images may vary from those shown
Adroll
adroll